Sermo, the largest global healthcare polling company and social platform for physicians, leveraged its capabilities to publish results of a COVID-19 study with more than 6,200 physicians in 30 countries. The study was completed in three days.
Hydroxychloroquine war rated the most effective therapy by those who used the medication.
Treatments & Efficacy
- The three most commonly prescribed treatments amongst COVID-19 treaters are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine
- Hydroxychloroquine usage amongst COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the U.S., 17% in Germany, 16% in Canada, 13% in the UK, and 7% in Japan.
- Hydroxychloroquine was overall chosen as the most effective therapy amongst COVID-19 treaters from a list of 15 options. (37% of COVID-19 treaters)
- 75% in Spain, 53% in Italy, 44% in China, 43% in Brazil, 29% in France, 23% in the U.S., and 13% in the UK.
- The two most common treatment regimens for Hydroxychloroquine were:
- (38%) 400mg twice daily on day one; 400 mg daily for five days
- (26%) 400mg twice daily on day one; 200mg twice daily for four days
- Outside the U.S., Hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients.
- Globally, 19% of physicians prescribed or have seen Hydroxychloroquine prophylactically used for high-risk patients, and 8% for low-risk patients.
A small controlled study in China found hydroxychloroquine to be ineffective.
Dr. Colyer discusses the treatment with Fox News host Laura Ingraham on her nightly show: